Cargando…
Efficacy of botulinum toxin in modifying spasticity to improve walking and quality of life in post-stroke lower limb spasticity - a randomized double-blind placebo controlled study
BACKGROUND: Post-stroke lower limb spasticity (PSLLS) has a prevalence of 28–37%. PSLLS can cause difficulty in walking and reduce quality of life (QOL). Post stroke spasticity impairs the ability to intervene to improve walking ability. Botulinum Toxin A (BT) is an effective intervention for focal...
Autores principales: | Datta Gupta, Anupam, Visvanathan, Renuka, Cameron, Ian, Koblar, Simon A., Howell, Stuart, Wilson, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6511142/ https://www.ncbi.nlm.nih.gov/pubmed/31078139 http://dx.doi.org/10.1186/s12883-019-1325-3 |
Ejemplares similares
-
A systematic review: efficacy of botulinum toxin in walking and quality of life in post-stroke lower limb spasticity
por: Gupta, Anupam Datta, et al.
Publicado: (2018) -
Spatiotemporal Gait Analysis and Lower Limb Functioning in Foot Dystonia Treated with Botulinum Toxin
por: Datta Gupta, Anupam, et al.
Publicado: (2018) -
Botulinum toxin type A in post-stroke lower limb spasticity: a multicenter, double-blind, placebo-controlled trial
por: Kaji, Ryuji, et al.
Publicado: (2010) -
Erratum to: Botulinum toxin type A in post-stroke lower limb spasticity: a multicenter, double-blind, placebo-controlled trial
por: Kaji, Ryuji, et al.
Publicado: (2010) -
Botulinum Toxin Treatment for Limb Spasticity in Childhood Cerebral Palsy
por: Pavone, Vito, et al.
Publicado: (2016)